New radiologist in Dornbirn: Early warning system for breast cancer remains strong!

New radiologist in Dornbirn: Early warning system for breast cancer remains strong!

Dornbirn, Österreich - In Dornbirn, there are changes in the area of breast cancer. Dr. Johannes Hoflehner, a respected radiologist, is retiring at the end of the year. His successor is Dr. Maria Anna Doppler-Feuerstein, which, according to the information of the Orf Vorarlberg, will take over the management of a new X-ray practice. While the exact location of her practice is still unclear, it has time to obtain the new premises by the end of March 2025. However, the Hofhlehner X -ray practice is not adopted, which leaves a gap in the supplying infrastructure.

The importance of breast cancer detection cannot be emphasized enough: In 2023, over 13,000 pension membership was carried out in Vorarlberg, and until April 2024 the number was already around 8,000. Women between 45 and 74 are automatically invited to participate in this life-saving program and can use the examinations free of charge with an e-card. For women between the ages of 40 and 45 and the age of 75, there is the possibility to register actively, which is emphasized by the Krebsinformationdienst . These findings are based on a variety of data that underline the direct connection between regular mammography and improved chances of recovery.

risk and early detection

The risk of developing breast cancer is greatly age -dependent and is also influenced by genetic factors. According to the experts, direct access to early detection is crucial, especially for women between the ages of 50 and 69, since 79 percent of the cases discovered in mammography have a favorable forecast. Women with a family risk have the opportunity to join intensified early detection programs that offer specific consultations and tests. These specialized centers work closely with the health insurance companies, so that the costs are usually covered, which represents another soothing aspect in the timely detection of breast cancer.